We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
-15.37%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$275M
AUM Growth
-$70.6M
Cap. Flow
-$17.2M
Cap. Flow %
-6.25%
Top 10 Hldgs %
93.23%
Holding
53
New
16
Increased
5
Reduced
4
Closed
26

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$12.2M
2
AMT icon
American Tower
AMT
+$3.76M
3
XENE icon
Xenon Pharmaceuticals
XENE
+$2.57M
4
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$2.47M
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$2.35M

Top Sells

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$6.45M
2
SWX icon
Southwest Gas
SWX
+$5.87M
3
FULC icon
Fulcrum Therapeutics
FULC
+$5.6M
4
CRBU icon
Caribou Biosciences
CRBU
+$4.32M
5
KALV
KalVista Pharmaceuticals
KALV
+$3.89M

Sector Composition

Rank Sector Weight
1 Healthcare 12.43%
2 Real Estate 1.96%
3 Consumer Staples 1.65%
4 Materials 0.96%
5 Utilities 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IE icon
26
Ivanhoe Electric
IE
$1.74B
$220K 0.08%
+25,246
New +$246K
SRZNW icon
27
Surrozen Inc Warrant
SRZNW
$8.86K
$24K 0.01%
+127,280
New +$28.7K
APLS
28
DELISTED
Apellis Pharmaceuticals
APLS
– –
-24,555
Closed -$1.25M
LONA
29
LeonaBio Inc
LONA
$72.1M
– –
-10,000
Closed -$1.35M
ATRA icon
30
Atara Biotherapeutics
ATRA
$76.1M
– –
-400
Closed -$93K
CDTX
31
DELISTED
Cidara Therapeutics
CDTX
– –
-18,455
Closed -$307K
CRBU icon
32
Caribou Biosciences
CRBU
$164M
– –
-470,000
Closed -$4.32M
FULC icon
33
Fulcrum Therapeutics
FULC
$297M
– –
-236,991
Closed -$5.6M
HESM icon
34
Hess Midstream
HESM
$5.11B
– –
-60,000
Closed -$1.8M
KALV
35
DELISTED
KalVista Pharmaceuticals
KALV
– –
-264,111
Closed -$3.89M
KNTK icon
36
Kinetik
KNTK
$7.98B
– –
-17,000
Closed -$551K
KREF
37
KKR Real Estate Finance Trust
KREF
$499M
– –
-42,220
Closed -$870K
MQ icon
38
Marqeta
MQ
$1.66B
– –
-3,750
Closed -$166K
MYPS icon
39
PLAYSTUDIOS Inc
MYPS
$90.1M
– –
-699,503
Closed -$3.39M
NWN icon
40
Northwest Natural Holdings
NWN
$2.12B
– –
-25,000
Closed -$1.29M
PLL
41
DELISTED
Piedmont Lithium
PLL
– –
-40,000
Closed -$2.92M
SEDG icon
42
SolarEdge
SEDG
$1.95B
– –
-20,000
Closed -$6.45M
SWX icon
43
Southwest Gas
SWX
$6.67B
– –
-75,000
Closed -$5.87M
TVTX icon
44
Travere Therapeutics
TVTX
$5.78B
– –
-100,000
Closed -$2.58M
TWST icon
45
Twist Bioscience
TWST
$7.25B
– –
-10,000
Closed -$494K
XLO icon
46
Xilio Therapeutics
XLO
$60.3M
– –
-11,648
Closed -$1.15M
CLYM
47
Climb Bio
CLYM
$804M
– –
-227,201
Closed -$1.91M
OMGA
48
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-123,614
Closed -$771K
NARI
49
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-25,000
Closed -$2.27M
THRN
50
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
– –
-111,250
Closed -$708K
1
2
3

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Monashee Investment Management held 53 positions worth $275M, down 20% from $345M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Monashee Investment Management withdrew a net $17.2M in Q2 2022, closing 26 positions and reducing 4 holdings. Its most notable exit was SolarEdge, an estimated $6.45M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 16% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, Monashee Investment Management opened a new position in American Tower worth $3.83M.

  • Monashee Investment Management's largest Q2 2022 buy was American Tower: 15,000 shares worth $3.83M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q2 2022, an estimated $12.2M increase.
  • Monashee Investment Management's biggest Q2 2022 reduction was AN2 Therapeutics, cutting an estimated $2.65M.
  • Monashee Investment Management fully exited SolarEdge in Q2 2022, selling an estimated $6.45M.
  • Monashee Investment Management's ten largest holdings make up 93% of its $275M portfolio in Q2 2022.
  • Monashee Investment Management opened 16 new positions and closed 26 in Q2 2022.
  • Monashee Investment Management's portfolio value fell 20% quarter-over-quarter to $275M.

Based on Monashee Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.